BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10820214)

  • 1. Oxidative modification of creatine kinase BB in Alzheimer's disease brain.
    Aksenov M; Aksenova M; Butterfield DA; Markesbery WR
    J Neurochem; 2000 Jun; 74(6):2520-7. PubMed ID: 10820214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders.
    Aksenova MV; Aksenov MY; Payne RM; Trojanowski JQ; Schmidt ML; Carney JM; Butterfield DA; Markesbery WR
    Dement Geriatr Cogn Disord; 1999; 10(2):158-65. PubMed ID: 10026391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein oxidation in the brain in Alzheimer's disease.
    Aksenov MY; Aksenova MV; Butterfield DA; Geddes JW; Markesbery WR
    Neuroscience; 2001; 103(2):373-83. PubMed ID: 11246152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
    Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease.
    Aksenov MY; Aksenova MV; Payne RM; Smith CD; Markesbery WR; Carney JM
    Exp Neurol; 1997 Aug; 146(2):458-65. PubMed ID: 9270056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain isoforms of creatine kinase in health and mental diseases: Alzheimer's disease and schizophrenia].
    Burbaeva GSh; Savushkina OK; Dmitriev AD
    Vestn Ross Akad Med Nauk; 1999; (1):20-4. PubMed ID: 10078058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine kinase BB in brain in schizophrenia.
    Burbaeva GSh; Savushkina OK; Boksha IS
    World J Biol Psychiatry; 2003 Oct; 4(4):177-83. PubMed ID: 14608589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning.
    David S; Shoemaker M; Haley BE
    Brain Res Mol Brain Res; 1998 Mar; 54(2):276-87. PubMed ID: 9555058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BB creatine phosphokinase activity and content of the brain structures in senile dementia and Alzheimer's diseases].
    Burbaeva GSh; Aksenova MV; Bibikova VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1374-8. PubMed ID: 3321799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Creatine phosphokinase distribution in the brain in schizophrenia and Alzheimer's disease].
    Aksenova MV; Karaseva NS; Burbaeva GSh
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(2):35-6. PubMed ID: 8048303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatine kinase-BB levels and cerebral cortical creatine kinase activity in senile dementia of the Alzheimer type.
    Court J; Ferrier N; Griffiths H; Lauffart B; Perry R; Candy J; Fairbairn A; Blessed G
    J Neurol Sci; 1987 Aug; 80(1):111-5. PubMed ID: 3612178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of serum creatine kinase isoenzyme BB in patients with malignancies.
    Abbott LB; Lott JA
    Clin Chem; 1984 Nov; 30(11):1861-3. PubMed ID: 6435914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.
    Hensley K; Hall N; Subramaniam R; Cole P; Harris M; Aksenov M; Aksenova M; Gabbita SP; Wu JF; Carney JM
    J Neurochem; 1995 Nov; 65(5):2146-56. PubMed ID: 7595501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and electrophoretic characteristics of creatine kinase BB extracted from human brain and intestine.
    Chastain SL; Ketchum CH; Grizzle WE
    Clin Chem; 1988 Mar; 34(3):489-92. PubMed ID: 3349597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of creatine kinase-BB isoenzyme in vitro: effect of carboxylic acids, thiols, pH, cations, and chelators.
    Lott JA; Heinz JW
    Clin Chem; 1982 Dec; 28(12):2414-7. PubMed ID: 7139922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decreased level of immunoreactive creatine phosphokinase BB isoenzymes in the brain of patients with schizophrenia and senile dementia of the Alzheimer type].
    Burbaeva GSh; Kalinenko OO; Aksenova MB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):85-7. PubMed ID: 2175101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymic, electrophoretic and immunoreactive properties of labeled MM and BB isoenzymes of human creatine kinase.
    Fang VS; Cho HW; Meltzer HY
    Enzyme; 1978; 23(3):210-4. PubMed ID: 738260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
    Castegna A; Aksenov M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    J Neurochem; 2002 Sep; 82(6):1524-32. PubMed ID: 12354300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct response to heparin by two chicken brain type creatine kinase subunits.
    Kataoka T; Yoneda M; Takeyama M; Ohno-Jinno A; Sugita I; Li H; Isogai Z; Iwaki M; Zako M
    Neurochem Int; 2009 Dec; 55(7):566-72. PubMed ID: 19465079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of enzymatic characteristics of creatine kinase BB from human healthy and tumor stomach tissues.
    Kanemitsu F; Okigaki T
    Clin Chim Acta; 1985 Sep; 151(1):23-31. PubMed ID: 4042368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.